Scholars Central

Conference abstractPublished 24 Aug 2016

Volatile compounds in the stem bark of Sclerocarya birrea (Anacardiaceae) possess antimicrobial activity against drug-resistant strains of Helicobacter pylori

Authors: Roland N Ndip, C Njume, A J Afolayan, E Green

University of Fort Hare, South Africa, University of Buea, Cameroon

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The aim of this study was to isolate and identify phytochemicals with anti-Helicobacter pylori activity from the stem bark of Sclerocarya birrea. The plant crude extract was fractionated by silica gel column and thin layer chromatography techniques; initially with ethyl acetate (EA) and subsequently with a combination of ethyl acetate/methanol/water (EMW). Further fractionation and identification of the phyto-constituents was achieved by gas chromatography and mass spectrometry (GC/MS) analysis. The antimicrobial activity of the fractions and compounds was evaluated against 5 metronidazole and clarythromycin-resistant strains of H. pylori and a reference strain ATCC 43526 using micro-broth dilution technique. Amoxicillin was included in these experiments as a positive control antibiotic. Sixteen of the 18 fractions collected demonstrated anti-H. pylori activity with minimum inhibitory concentration (MIC50) values ranging from 310-2500 µg/mL. Two of the fractions; EMW fraction 6 and EA fraction 1 revealed the presence of 5 and 24 compounds respectively representing 40.5% and 86.57% of the total composition. Most of the compounds were essential oils with terpinen-4-ol being the most abundant agent (35.83 %), followed by pyrrolidine (32.15 %), aromadendrene (13.63%) and α-gujunene (8.77%). MIC50 values for amoxicillin, terpinen-4-ol and pyrrolidine ranged from 0.0003-0.06 µg/mL, 0.004-0.06 µg/mL and 0.005-6.3 µg/mL respectively. The inhibitory activities of terpinen-4-ol and pyrrolidine were similar to amoxicillin (P>0.05). Most of these compounds are being reported in this plant for the first time and may represent new sources of therapeutically useful compounds against H. pylori.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectInfectious Diseases
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Roland N Ndip”
  • BylineArticles whose byline prints “C Njume”
  • BylineArticles whose byline prints “A J Afolayan”
  • BylineArticles whose byline prints “E Green”